Modifications of plasma fibronectin in cystic fibrosis patients

L Stanislawski1, M Sorin

  • 1Institut National de la Santé et de la Recherche Médicale (U.294), CHU 7 Xavier Bichat, Université Paris 7, France.

Insights

Cystic fibrosis (CF) patients show reduced binding of fibronectin (FN) to bacteria like Staphylococcus aureus. This altered fibronectin may contribute to recurrent lung infections in CF, impacting respiratory health.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Biochemistry

Background:

  • Recurrent pulmonary infections by Staphylococcus aureus and Pseudomonas aeruginosa are a significant challenge in cystic fibrosis (CF).
  • These infections lead to progressive respiratory deterioration in CF patients.
  • Fibronectin (FN), a protein involved in cellular adhesion, possesses binding sites for bacteria such as S. aureus.

Purpose of the Study:

  • To investigate the bacterial binding characteristics of fibronectin (FN) from cystic fibrosis (CF) patients.
  • To compare CF-derived FN with FN from bronchitis and normal subjects.

Main Methods:

  • Purification of fibronectin (FN) from plasma of CF patients, bronchitis patients, and normal subjects.
  • Enzyme-linked immunosorbent assay (ELISA) technique to assess bacterial binding to FN.
  • Polyacrylamide gel electrophoresis (PAGE) to analyze peptide migration patterns after proteinase hydrolysis.
  • Quantification of total sugar content in FN samples.

Main Results:

  • A significant decrease in the binding of CF-derived FN to S. aureus and Streptococcus pyogenes was observed in all seven CF patients studied.
  • Marked alterations in peptide migration patterns were noted in CF FN compared to normal FN after enzymatic hydrolysis.
  • Variations in total sugar content (increase or decrease) were found in CF FN.

Conclusions:

  • Fibronectin from cystic fibrosis patients exhibits reduced binding affinity for key respiratory pathogens.
  • Structural and compositional modifications in CF fibronectin may play a role in the susceptibility to recurrent bacterial lung infections.
  • These findings suggest fibronectin alterations as a potential factor contributing to the pathophysiology of cystic fibrosis lung disease.

Related Concept Videos

Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...